News RiMO Therapeutics Announces Enrollment of the First Patient in Phase 1 Study of RiMO-301 with Radiation in Advanced Tumors
News Multifunctional Nanomedicine Developed Using Novel UChicago Tech Gets FDA Nod to Initiate Clinical Trials Coordination Pharmaceuticals, Inc. (CPI) recently announced that the FDA has approved the company’s Investigational New Drug (IND) application to initiate a first-in-human Phase 1 clinical study of its novel cancer...
